Outcomes associated with warfarin time in therapeutic range among US veterans with nonvalvular atrial fibrillation

201724 citationsJournal Article

Authors

Shuqian Liu · Tulane University

Xiaoyan Li · Bristol-Myers Squibb (United States)

Qian Shi · Tulane University

Melissa Hamilton · Bristol-Myers Squibb (United States)

Keith Friend · Bristol-Myers Squibb (United States)

Yingnan Zhao · Xavier University of Louisiana

Ruslan Horblyuk

Abstract

The observed quality of warfarin control in VA EMR suggests room for improvement given the association with elevated risk of adverse clinical outcomes.

Topics & Keywords

Atrial Fibrillation Management and Outcomes Blood Pressure and Hypertension Studies Venous Thromboembolism Diagnosis and Management

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Current Medical Research and Opinion

Volume 34, Issue 3, pp. 415-421

DOI: 10.1080/03007995.2017.1384370

Field-Weighted Citation Impact: 2.10